Drug General Information
Drug ID
D0GR2H
Former ID
DNC014587
Drug Name
BMY-44621
Drug Type
Small molecular drug
Indication Discovery agent Terminated [545449]
Structure
Download
2D MOL

3D MOL

Formula
C19H27N5O3
Canonical SMILES
C1CC(N(C1)C(=O)CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C=O
InChI
1S/C19H27N5O3/c20-19(21)22-10-4-8-15(13-25)23-18(27)16-9-5-11-24(16)17(26)12-14-6-2-1-3-7-14/h1-3,6-7,13,15-16H,4-5,8-12H2,(H,23,27)(H4,20,21,22)/t15-,16-/m0/s1
InChIKey
FWMLVCYBCSOEBZ-HOTGVXAUSA-N
PubChem Compound ID
Target and Pathway
Target(s) Trypsin Target Info Inhibitor [551325]
KEGG Pathway Neuroactive ligand-receptor interaction
Pancreatic secretion
Protein digestion and absorption
Influenza A
Reactome Activation of Matrix Metalloproteinases
Cobalamin (Cbl, vitamin B12) transport and metabolism
WikiPathways Activation of Matrix Metalloproteinases
References
Ref 545449Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003308)
Ref 551325Design and synthesis of conformationally constrained arginal thrombin inhibitors, Bioorg. Med. Chem. Lett. 7(17):2205-2210 (1997).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.